Tag: facility in Songdo
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Featured Article
Reducing downtime through real-time shop floor insights with Minitab’s Prolink
Unplanned downtime remains one of the most costly – and often misunderstood – challenges on the manufacturing floor.
